Devex | January 20, 2023
Aug. 26 — Moderna sues Pfizer and BioNTech for patent infringement in the development of a messenger RNA COVID-19 vaccine, alleging that the companies copied the technology from Moderna.
“Moderna’s IP suit against Pfizer/BioNTech is bad for public health. Both have had huge windfalls. Moderna got billions in US funding. The suit would push mRNA vaccines into a near monopoly & stifle innovation. The public loses. Both companies should waive IP & transfer technology,” tweets public health expert Lawrence Gostin, who is director of the O’Neill Institute.